Respiratory Relief

Manufacturer
Schwabe North America, Inc
Effective date
2025-07-29
Label type
HUMAN OTC DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 01:08:54

Label at a glance#

ProductRespiratory Relief
Active ingredientGUAIFENESIN
Label structure10 sections

Label contents#

Full prescribing information#

Active Ingredient

OTC - ACTIVE INGREDIENT SECTION

Guaifenesin 400 mg

Inactive Ingredients

INACTIVE INGREDIENT SECTION

Carnauba Wax

Cellulose

Glycerin

Hypromellose

Magnesium Stearate

Maltodextrin

Povidone

Silica

Sodium Croscarmellose

Stearic Acid

Dosage & Administration

DOSAGE & ADMINISTRATION SECTION

Adults & children 12 years of age and older:  take 1 tablet every 4 hours with a full glass of water while symptoms persist. Do not to exceed 6 tablets in 24 hours.

Children under 12 years of age: do not use.

Purpose

OTC - PURPOSE SECTION

Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.

Indications & Usage

INDICATIONS & USAGE SECTION

Helps loosen phlegm (mucus) and thin bronchial secretions to rid the bronchial passageways of bothersome mucus and make coughs more productive.

Warnings

WARNINGS SECTION

Do not use for children under 12 years of age.

Ask a doctor

OTC - ASK DOCTOR SECTION

Ask a doctor before use if you have a persistent or chronic cough such as occurs with smoking, asthma, chronic bronchitis, or emphysema, a cough accompanied by excessive phlegm (mucus).

Stop Use

OTC - STOP USE SECTION

Stop use and ask a doctor if cough lasts more than 7 days, tends to recur, or is accompanied by a fever, rash or persisient headache.

A persistent cough may be a sign of a serious condition.

Keep out of Reach of Children

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children.

Pregnant or Breast Feeding

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a healthcare professional before use.

Overdosage:

OVERDOSAGE SECTION

In case of overdose, seek medical help or contact a Poison Control Center right away.

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

LHBN15295_01_RespiratoryRelief_Ctn_30ct_FNL.jpgLHBN15295_01_RespiratoryRelief_Ctn_30ct_FNL.jpg

LH15295_01_RespiratoryRelief_Lbl_30ct_FNL.jpgLH15295_01_RespiratoryRelief_Lbl_30ct_FNL.jpg

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
359601guaiFENesin 400 MG Oral TabletPSN1
359601guaifenesin 400 MG Oral TabletSCD1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
GUAIFENESIN Pharmacologic Class Indexing1Indexing - Pharmacologic Class20211129

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
53499-5295-0Respiratory Relief30 in 1 BOTTLETABLET301

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 12 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
53499-529553499-5295-0

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 11 matching rows.

Source Document#

Source XML

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Respiratory ReliefGUAIFENESINSchwabe North America, Incf683041a-4ff9-42a5-9047-a9a3140a87582025-07-29WarningsExact identifier
ndc (package): 53499-5295-0
ndc (product): 53499-5295
ndc11 (package): 53499529500
spl id: 6465861b-e970-4f26-8c90-2ee4a6323723
spl set id: f683041a-4ff9-42a5-9047-a9a3140a8758

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.